Measles virus-specific T helper 1/T helper 2-cytokine production in subacute sclerosing panencephalitis. NLM AIDSLINE Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Measles virus-specific T helper 1/T helper 2-cytokine production in subacute sclerosing panencephalitis.

J Neurovirol. 2000 Apr;6(2):121-6. Unique Identifier : AIDSLINE MED/20284033
Hara T; Yamashita S; Aiba H; Nihei K; Koide N; Good RA; Takeshita K; Department of Pediatrics, Graduate School of Medical Sciences,; Kyushu University, Fukyoka, Fukuoka, Japan.


Abstract: Live measles virus-specific T helper 1/T helper 2-cytokine productions by peripheral blood mononuclear cells in response to live measles, mumps or varicella virus were measured in 15 patients with subacute sclerosing panencephalitis and 15 controls by enzyme-linked immunosorbent assays. Most patients with subacute sclerosing panencephalitis had a defect in measles virus-specific production of interferon-gamma, one of the T helper 1 type cytokines, despite persistent presence of measles virus, with preserved interleukin-10 (T helper 2 type cytokine) synthesis. Patients with subacute sclerosing panencephalitis were divided into two groups: responders (group A) with significant interferon-gamma production (>20 pg/mL) in response to live measles virus and non-responders (group B) with a little or no interferon-gamma production. Comparison of the clinical courses between groups A and B revealed that all the patients of group A retained receptive function for a long time, while most patients of group B lost the function rapidly (P<0.01). An inverse correlation between interferon-gamma production by peripheral blood mononuclear cells and disease progression suggested that interferon-gamma plays an antiviral role in subacute sclerosing panencephalitis.
Keywords: JOURNAL ARTICLE Adolescence Adult Chickenpox Vaccine/IMMUNOLOGY Child Child, Preschool Comparative Study Disease Progression Enzyme-Linked Immunosorbent Assay Female Human Immunity, Cellular Interferon Type II/BIOSYNTHESIS/DEFICIENCY/*PHYSIOLOGY/SECRETION Interleukins/BIOSYNTHESIS/SECRETION Lymphokines/*BIOSYNTHESIS/SECRETION Male Measles Vaccine/*IMMUNOLOGY Measles Virus/*IMMUNOLOGY/PATHOGENICITY Mumps Vaccine/IMMUNOLOGY Subacute Sclerosing Panencephalitis/*IMMUNOLOGY/VIROLOGY Support, Non-U.S. Gov't Th1 Cells/*SECRETION Th2 Cells/*SECRETION Vaccines, Attenuated/IMMUNOLOGYKWDjournalarticleadolescenceadultchickenpoxvaccine/immunologychildchild,preschoolcomparativestudydiseaseprogressionenzyme-linkedimmunosorbentassayfemalehumanimmunity,cellularinterferontypeii/biosynthesis/deficiency/KWDphysiology/secretioninterleukins/biosynthesis/secretionlymphokines/KWDbiosynthesis/secretionmalemeaslesvaccine/KWDimmunologymeaslesvirus/KWDimmunology/pathogenicitymumpsvaccine/immunologysubacutesclerosingpanencephalitis/KWDimmunology/virologysupport,non-uKWDsKWDgov'tth1cells/KWDsecretionth2cells/KWDsecretionvaccines,attenuated/immunology
001030
A00A1094

Copyright © 2000 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .